| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |